IL12RB1 and infectious disease: Second, the clinical penetrance of mutations, in terms of infectious diseases can be low, as observed in MSMD for patients with complete IL-12Rβ1 deficiency [20], or even extremely low, as in patients with autosomal dominant IFN-γR2 deficiency [25].